Article
Usefulness of Genetic Testing in PD and PD Trials: A Balanced Review.
Journal of Parkinson's disease - 1 Jan 2015
Gasser Thomas
Abstract excerpt
An increasing proportion of the individual and population risk to develop Parkinson's disease (PD) can be explained by genetic variants of different effect strength, forming a continuum from rare high penetrance gain or loss of function mutations to relatively common genetic risk variants that only mildly modify disease risk. In the coming years, further advances in molecular genetic technologies, in particular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
